Old Web
English
Sign In
Acemap
>
authorDetail
>
William Caldwell
William Caldwell
Eli Lilly and Company
Carcinoma
Ramucirumab
Placebo
Pathology
Gastro-
2
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract A12: The CDK4/CDK6 inhibitor abemaciclib inhibits transcriptional targets which facilitate growth in ER+ breast cancer cells
2016
Molecular Cancer Research
Ann M. McNulty
Teresa Burke
Jack Dempsey
Christophe C. Marchal
Andrew E. Schade
Hadrian Szpurka
Michele Dowless
Jennifer R. Stephens
Denise Edmondson
Keith R. Stayrook
William Caldwell
Sean Buchanan
Farhana F. Merzoug
Richard P. Beckmann
Show All
Source
Cite
Save
Citations (0)
Candidate biomarker analyses in gastric or gastro-esophageal junction carcinoma: REGARD trial of single-agent ramucirumab (RAM) vs. placebo (PL).
2015
Journal of Clinical Oncology
Charles S. Fuchs
Josep Tabernero
Jiri Tomasek
Ian Chau
Bohuslav Melichar
Howard Safran
Mustapha Tehfe
Filip Dumitru
Eldar Topuzov
Luis Schlittler
Anghel Adrian Udrea
William Campbell
Stephen Brincat
Michael Emig
Symantha Melemed
Rebecca R. Hozak
David Ferry
William Caldwell
Jaffer A. Ajani
Show All
Source
Cite
Save
Citations (5)
1